Allakos Inc. Files Q1 2025 10-Q
| Field | Detail |
|---|---|
| Company | Allakos Inc. |
| Form Type | 10-Q |
| Filed Date | May 7, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-Q, pharmaceuticals, financials
TL;DR
Allakos Q1 2025 10-Q filed. Financials and biz updates out.
AI Summary
Allakos Inc. filed its 10-Q for the period ending March 31, 2025. The filing details financial performance and operational updates for the first quarter of 2025. Key financial data and disclosures related to the company's pharmaceutical preparations business are included.
Why It Matters
This filing provides investors with a quarterly update on Allakos Inc.'s financial health and operational progress in the pharmaceutical sector.
Risk Assessment
Risk Level: medium — As a pharmaceutical company, Allakos faces inherent risks related to drug development, regulatory approvals, and market competition.
Key Numbers
- 20250331 — Reporting Period End Date (Indicates the end of the fiscal quarter being reported.)
- 20250507 — Filing Date (The date the 10-Q was officially submitted to the SEC.)
Key Players & Entities
- Allakos Inc. (company) — Filer of the 10-Q
- 20250331 (date) — End of reporting period
- 20250507 (date) — Filing date
- San Carlos, CA (location) — Company headquarters
FAQ
What is the primary business of Allakos Inc. as indicated by its SIC code?
Allakos Inc.'s Standard Industrial Classification (SIC) code is 2834, which corresponds to Pharmaceutical Preparations.
What is the fiscal year end for Allakos Inc.?
Allakos Inc.'s fiscal year ends on December 31.
When was the 'San Carlos Lease Agreement' entered into?
The 'San Carlos Lease Agreement' is associated with the period ending December 31, 2019.
What type of equity offering is mentioned in the filing?
The filing mentions an 'At The Market Equity Offering' that occurred on August 4, 2022.
What is the filing date for this 10-Q report?
This 10-Q report was filed on May 7, 2025.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 7, 2025 regarding Allakos Inc..